WPI 3171 (Alendronate 35 mg)

Pill imprint WPI 3171 has been identified as Alendronate sodium 35 mg.

Alendronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WPI 3171

Alendronate sodium 35 mg WPI 3171
Alendronate sodium 35 mg WPI 3171
Alendronate sodium
Imprint:
WPI
3171
Strength:
35 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3171
Inactive Ingredients:
magnesium stearate
mannitol
microcrystalline cellulose
sodium starch glycolate type A potato
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
21695-0901 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)